as reported by Rick Ruggles.
Gout, perhaps the most painful chronic disease, afflicts at least 3 million Americans, and is treated with colchicine, a drug so old it was grandfathered in under a 1938 law requiring new drugs to be evaluated by the FDA. In 2009 the FDA awarded URL Pharma three years of market exclusivity for Colcrys (colchicine). But in the same year the patent office gave URL a 20-year patent. The drug now costs fifty times more than it used to, going from ten cents to five dollars per pill.